Login / Signup

Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.

Jonathan WickelHa-Yeun ChungStephanie PlatzerThomas LehmannHarald PrüssFrank LeypoldtAlbrecht GüntherAndré ScheragChristian Geisnull null
Published in: Trials (2020)
Clinicaltrials.gov , NCT03993262 . Registered June 20, 2019; German Clinical Trials Register, DRKS00017497.
Keyphrases
  • double blind
  • clinical trial
  • placebo controlled
  • open label
  • phase ii
  • phase iii
  • multiple myeloma
  • drug induced
  • multiple sclerosis
  • study protocol
  • early onset
  • newly diagnosed
  • randomized controlled trial